Researchers repurpose failed cancer drug into printable semiconductor

Chemical and biomolecular engineering professor Ying Diao and collaborators have repurposed a failed cancer drug into a new type of organic semiconductor for use in transistors and chemical sensors. Photo by L. Brian Stauffer

OCT 2, 2019 9:30 AM
LOIS YOKSOULIAN

Summary
Researchers repurpose failed cancer drug into printable semiconductor
Article Name
Researchers repurpose failed cancer drug into printable semiconductor
Description
Many potential pharmaceuticals end up failing during clinical trials, but thanks to new research from the University of Illinois, biological molecules once considered for cancer treatment are now being repurposed as organic semiconductors for use in chemical sensors and transistors.